AGPU

Axe Compute is not an operating business in any conventional sense — it is a micro-cap shell with a history of serial rebranding (SKLN → AIPT → POAI → AGPU, the AGPU ticker live only since Dec 12, 2025) that has pivoted into a crypto-treasury vehicle. FY2025 revenue was $125K (yes, thousand) against a net loss of $233M; net margin is literally -186,053% and ROE is -488%. The accumulated deficit sits at -$414M. The headline P/E of 20.9 is a data artifact — it divides today's price by FY2021 diluted EPS of $0.36, a figure five years stale and irrelevant to a company now losing nine figures. The honest valuation read is P/S of 333x on revenue that is rounding-error scale and a balance sheet whose 'value' is about to be concentrated in a single, volatile digital asset.

The MD&A makes the risk explicit: management is reallocating 'a significant portion of the Company's balance sheet' into ATH, the Aethir network token, and states plainly that assets 'will be highly concentrated in a single digital asset' such that 'adverse developments specific to ATH, its protocol, or its network could have a disproportionate impact.' This is a leveraged, undiversified crypto bet wrapped in a NASDAQ listing — the GPU-compute and AI narrative (TAM citations of $1T+ markets, McKinsey, Gartner) is aspiration, not revenue; the company 'plans to operate' as an infrastructure provider and is still 'evaluating strategic alternatives' for its legacy oncology/Helomics biobank. There is no demonstrated compute business attached to the trillion-dollar story.